SLC5A2 and hydrops fetalis: Accordingly, the aim of this systematic review and meta-analysis was to evaluate data from recent studies that investigated the effect of SGLT2 inhibitors on patient quality of life (QoL) and cardiovascular (CV) outcomes, including CV death, hospitalization for HF (HHF), urgent visit for HF, and all-cause death, in patients with HFmrEF or HFpEF.